Department of Internal Medicine, University of Pisa, Pisa, Italy.
J Am Coll Cardiol. 2011 Jul 12;58(3):238-47. doi: 10.1016/j.jacc.2011.01.050.
The aim of this study was to assess whether small arteries from visceral fat of obese patients show a reduced nitric oxide (NO)-dependent relaxation, as compared with lean control subjects, focusing on the role of the pro-inflammatory cytokine tumor necrosis factor (TNF)-α.
Visceral obesity is characterized by endothelial dysfunction.
Small arteries from 14 obese (body mass index 48.4 ± 11 kg/m(2)) and 14 control subjects (body mass index 24.9 ± 2 kg/m(2)), dissected after a visceral fat biopsy (laparoscopy), were evaluated on a pressurized micromyograph. Endothelium-dependent relaxation was assessed by acetylcholine. The NO availability, superoxide production, and inflammation were assessed by testing acetylcholine under the nitric oxide synthase (NOS) inhibitor N(ω)-nitro-L-arginine methylester, tempol (superoxide scavenger), and infliximab (monoclonal anti-TNF-α antibody), respectively. The roles of nicotinamide adenine dinucleotide phosphate oxidase and inducible nitric oxide synthase (iNOS) were assessed by their selective inhibitors apocynin and S-methylisothiourea (SMT), respectively. Vascular superoxide generation (dihydroethidium staining) protein expression of TNF-α and NOS isoforms (Western Blot) and TNF-α localization (immunohistochemistry) were assessed.
Vessels from obese patients displayed a blunted relaxation to acetylcholine and a reduced inhibitory effect of N(ω)-nitro-L-arginine methylester. These alterations were normalized by tempol or infliximab while being partly ameliorated by apocynin and SMT. Vascular superoxide generation was increased (p < 0.01) in obese patients. This condition was abrogated by both tempol and infliximab and partly (p < 0.05 vs. control subjects) reduced by apocynin or SMT. Enhanced TNF-α and iNOS expression together with increased TNF-α localization in the vascular media were detected.
Small arteries from visceral fat of obese patients are characterized by an increased TNF-α production, which reduces NO availability by promoting superoxide generation via nicotinamide adenine dinucleotide phosphate oxidase and iNOS activation.
本研究旨在评估肥胖患者内脏脂肪中的小动脉是否与瘦对照受试者相比表现出一氧化氮(NO)依赖性舒张减少,并重点关注促炎细胞因子肿瘤坏死因子(TNF)-α的作用。
内脏肥胖的特征是内皮功能障碍。
对 14 名肥胖患者(体重指数 48.4 ± 11kg/m²)和 14 名对照受试者(体重指数 24.9 ± 2kg/m²)的内脏脂肪活检(腹腔镜)后分离出的小动脉,在加压微测图上进行评估。乙酰胆碱评估内皮依赖性舒张。通过测试乙酰胆碱在一氧化氮合酶(NOS)抑制剂 N(ω)-硝基-L-精氨酸甲酯、tempol(超氧化物清除剂)和英夫利昔单抗(单克隆抗 TNF-α 抗体)下,分别评估 NO 可用性、超氧化物产生和炎症。通过其选择性抑制剂 apocynin 和 S-甲基异硫脲(SMT),分别评估烟酰胺腺嘌呤二核苷酸磷酸氧化酶和诱导型一氧化氮合酶(iNOS)的作用。评估血管超氧化物生成(二氢乙啶染色)、TNF-α 和 NOS 同工型的蛋白表达(Western Blot)以及 TNF-α 定位(免疫组织化学)。
肥胖患者的血管对乙酰胆碱的舒张反应减弱,对 N(ω)-硝基-L-精氨酸甲酯的抑制作用降低。这些变化通过 tempol 或英夫利昔单抗得到了纠正,而通过 apocynin 和 SMT 则部分得到了改善。肥胖患者的血管超氧化物生成增加(p < 0.01)。这种情况被 tempol 和英夫利昔单抗消除,而通过 apocynin 或 SMT 部分(与对照受试者相比 p < 0.05)减少。检测到增强的 TNF-α 和 iNOS 表达以及血管中膜中 TNF-α 的定位增加。
肥胖患者内脏脂肪中的小动脉的特征是 TNF-α 产生增加,这通过激活烟酰胺腺嘌呤二核苷酸磷酸氧化酶和 iNOS 来促进超氧化物生成,从而降低 NO 的可用性。